← Open Payments lookup

JESSICA AL KHALIDI: Open Payments

NPI 1760143275 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,435 in 65 payments from 16 companies in 2025. Trend: 2023 $1,720 · 2024 $1,933 · 2025 $1,435

Food & beverage: $1,335Education: $100
CompanyPaymentsAmount
Janssen Biotech, Inc.13$333
ABBVIE INC.10$201
Ardelyx, Inc.4$138
Celltrion USA Inc.5$107
Lilly USA, LLC5$103
Takeda Pharmaceuticals U.S.A., Inc.4$76
Madrigal Pharmaceuticals3$74
Ipsen Biopharmaceuticals, Inc3$71
PFIZER INC.4$69
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$56

Products named: TREMFYA, IBSRELA, LINZESS, VEGZELMA, OMVOH, EOHILIA, REZDIFFRA, IQIRVO.

Industry payments across TX — which companies pay providers there.